Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02307240
Title Open Label, Multi-center Study to Assess the Safety, Tolerability and Pharmacokinetics of CUDC-907 in Subjects With Advanced/Relapsed Solid Tumors
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors Curis, Inc.
Indications

breast cancer

ovarian cancer

Advanced Solid Tumor

triple-receptor negative breast cancer

NUT midline carcinoma

Therapies

CUDC-907

Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.